Phlegmon

Jump to navigation Jump to search

WikiDoc Resources for Phlegmon

Articles

Most recent articles on Phlegmon

Most cited articles on Phlegmon

Review articles on Phlegmon

Articles on Phlegmon in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Phlegmon

Images of Phlegmon

Photos of Phlegmon

Podcasts & MP3s on Phlegmon

Videos on Phlegmon

Evidence Based Medicine

Cochrane Collaboration on Phlegmon

Bandolier on Phlegmon

TRIP on Phlegmon

Clinical Trials

Ongoing Trials on Phlegmon at Clinical Trials.gov

Trial results on Phlegmon

Clinical Trials on Phlegmon at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Phlegmon

NICE Guidance on Phlegmon

NHS PRODIGY Guidance

FDA on Phlegmon

CDC on Phlegmon

Books

Books on Phlegmon

News

Phlegmon in the news

Be alerted to news on Phlegmon

News trends on Phlegmon

Commentary

Blogs on Phlegmon

Definitions

Definitions of Phlegmon

Patient Resources / Community

Patient resources on Phlegmon

Discussion groups on Phlegmon

Patient Handouts on Phlegmon

Directions to Hospitals Treating Phlegmon

Risk calculators and risk factors for Phlegmon

Healthcare Provider Resources

Symptoms of Phlegmon

Causes & Risk Factors for Phlegmon

Diagnostic studies for Phlegmon

Treatment of Phlegmon

Continuing Medical Education (CME)

CME Programs on Phlegmon

International

Phlegmon en Espanol

Phlegmon en Francais

Business

Phlegmon in the Marketplace

Patents on Phlegmon

Experimental / Informatics

List of terms related to Phlegmon

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Phlegmon is a spreading diffuse inflammatory process with formation of suppurative/purulent exudate or pus.

Etiology

Commonly by bacteria - staphylococci, streptococci, pneumococci, spore and non-spore forming anaerobes, etc.

Factors affecting the development of phlegmons are virulence of bacteria and human's immunity strength defenses.

Classifications

By clinical course

  1. Acute
  2. Subacute

By severity of condition

  1. Mild
  2. Average
  3. Severe (with spreading to other location(s))

By location

  1. Superficial
a)cutaneous
b)subcutaneous
c)interstitial tissue
d)intramuscular
  1. Deep
e)mediastinal
f)retroperitoneal

By etiology

a)single b)mix (eg:spore and non-spore forming anaerobes)

By pathogenesis

a)per continuitatem (through neighbouring tissues) b)hematogenous (through non-valvular veins like venous plexus of face eg: v. pterygoideus plexus → inflamation of veins (phlebitis) → thrombus formation in veins → embolization of thrombus into sinus venousus systems) c)odontogenous

By exudative character

a)purulent phlegmon b)purulent-hemorrhagic phlegmon c)putrefactive phlegmon

By presence of complications

a)with complications (disturbance of mastication, ingestion, speech, cardiovascular and respiratory system, peritonitis, lymphadenitis, loss of conscious if very severe, etc) b)without complication

Clinical Pictures

1)Systemic features of infection like increased body temperature (up to 38-40°C), general fatigue, chills, sweatings, headache, loss of appetite). 2)Inflammatory signs - dolor(localized pain), calor(increase local tissue temperature), rubor (skin redness/hyperemia), tumor(either clear or non-clear bordered tissue swelling), functio laesa(diminish affected function).

NB: severity of patient condition with phlegmons is directly proportional to the degree of intoxication level i.e the severe the condition, the higher degree of intoxication level.

Diagnostics

  1. Complaints and clinical appearances
  2. Anamnesis
  3. Visual and Palpations
  4. Blood test - leucocytosis (up to 10-12x109/L), decrease or absence eosinophils level, shift of leucocyte formula to the left (neutrophilos), increase ESR (up to 35-40 mm/hr).
  5. Urine test - presence of bacteria in urine, increase urinary leucocyte counts.
  6. X-ray test
  7. Ultrasound test on pus

Treatments

The main goal treatment remove the cause of phlegmonous process in order to achieve effective treatment and prevention of residives.

If patients condition is mild and the signs of inflammatory process is presence without signs of infiltrates, then conservative treatment with antibiotics is sufficient.

In severe condition, immediate operation is necessary with application of drainage system. All of these are done under general anaesthesia. During operation, the cavity or place of phlegmonous process are washed with antiseptic, antibiotic solutions and proteolyic ferments.

In post-operative period, i/v drips of detoxification, antibiotics, haemosorbtion, vitaminotherapy. Additionally, the use of i/v or i/m antistaphylococci γ-globulin or anatoxin can be taken as immunotherapy.

During operation of phlegmon dissection at any location, it is important:

  1. to avoid spreading of pus during operation
  2. take into account the cosmetic value of operating site especially phlegmmonous process of face.
  3. during dissection, avoid damaging nerves especially facial nerves. Use the correct incision line.

Template:SIB

de:Phlegmone et:Flegmoon nl:Flegmone

Template:WH Template:WS